1. PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
   Yuriy Vinnik et al, 2020, EUREKA: Health Sciences CrossRef
2. Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue
   Sung Hee Hwang et al, 2008, Molecular Cancer Therapeutics CrossRef
3. Proteomic characterization of cytoskeletal and mitochondrial class III β-tubulin
   Lucia Cicchillitti et al, 2008, Molecular Cancer Therapeutics CrossRef
4. RETRACTED: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes
   Joe Abdo et al, 2017, Frontiers in Oncology CrossRef
5. Energy Metabolic Plasticity of Colorectal Cancer Cells as a Determinant of Tumor Growth and Metastasis
   Leenu Reinsalu et al, 2021, Frontiers in Oncology CrossRef
6. Intracellular β-Tubulin/Chaperonin Containing TCP1-β Complex Serves as a Novel Chemotherapeutic Target against Drug-Resistant Tumors
   Yuan-Feng Lin et al, 2009, Cancer Research CrossRef
7. Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10
   Pascal Sève et al, 2007, Clinical Cancer Research CrossRef
8. Molecular Mechanisms of Patupilone Resistance
   Simona Mozzetti et al, 2008, Cancer Research CrossRef
9. From plasma membrane to cytoskeleton: a novel function for semaphorin 6A
   Silvia Prislei et al, 2008, Molecular Cancer Therapeutics CrossRef